Will - Pharma
ActiveDirectors
Directors
2 directors, 1 in day-to-day management, last change in 2026
Board 2
MAGILITY
Current
Director · since 01-08-2024 · 6-year term from 2024 · Private limited company · permanent representative: Maurienne Will · also on the board of 1 other company · listed in the 2025 annual accounts, filed on 06-07-2026
Daniel DELATTE
Current
Director · in office according to the act of 21-10-2026 · one-year term from 2026
Day-to-day management 1
MAGILITY
Current
Managing director · appointed in the act of 11-12-2024 · 6-year term from 2024 · Private limited company · permanent representative: Maurienne Will
Permanent representatives 1
Maurienne Will
Current
Permanent representative · appointed in the act of 11-12-2024 · for MAGILITY
Statutory auditor 1
ALL ABOUT AUDIT
Current
Statutory auditor · current term since 14-05-2025 · 3-year term from 2025 · permanent representative: Nadja De Buyser · listed in the 2025 annual accounts, filed on 06-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 18. Pouvois et fonctionnement de l’organe d’administration. S’il n’y a qu’un seul administrateur, la totalité des pouvoirs…”
deed of 13-01-2023Owners and capital
Shareholders
1 ownerChain of control
- DEPHARM
- Will - Pharma
Owners 1
- DEPHARMparentSourceaccounts DEPHARM 2025Equity €25.3m Profit of €122,905 in 2025 (profit of €71,767 in 2024) Checked score 91100%
Capital transactions
Shareholders according to the deeds
Stated in the act
act of 31-08-2022 ↗
- M.V.V.M. SRL all shares
Capital over time
- 13-01-2023 Capital stated in the deed · €2,970,000 · 2,357 shares
Mandate history
4 people, 3 in office
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Daniel DELATTE |
|
| MAGILITY |
|
| ALL ABOUT AUDIT |
|
| M.V.V.M. |
|